Empowering States to Address Drug Costs Act
Latest action · Jul 24, 2019 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 24, 2019
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Empowering States to Address Drug Costs Act
This bill expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.
Cosponsors 1
Members who signed on, in the order they did. All signed on Jul 24, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MD | Benjamin L. Cardin | Original | Jul 24, 2019 |
Actions 2
Everything that happened, newest first.
- Jul 24, 2019Introduced in Senate
- Jul 24, 2019Read twice and referred to the Committee on Finance.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jul 24, 2019Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.
